InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,450.51
(
0.95%
)
US TECH 100
18,452.40
(
0.66%
)
Dow Jones
40,540.82
(
1.52%
)
Brent Oil
79.98
(
-1.91%
)
Bitcoin
67,465.24
(
2.55%
)
Post# of 252690
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Titan V

Send PM Follow Ignore
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Titan V

Re: DewDiligence post# 218051

Thursday, 03/22/2018 11:47:24 AM

Thursday, March 22, 2018 11:47:24 AM

Post# of 252690
Fair point IMO. However Leerink seems to be doubting the platform.

"(AbbVie) needs something that is the cornerstone of the oncology franchise that they own and Rova-T was meant to be that," Porges said. "And now that cornerstone is cracked you wonder if they don't have to go out and find something else."


https://www.nasdaq.com/article/abbvies-lung-cancer-drug-data-disappoints-shares-slump-20180322-00878/amp
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up